Long Ideas - Sucampo Pharmaceuticals (NASDAQ: SCMP) and marketing partner Takeda, announced the filing of a supplemental NDA (sNDA) for Amitiza for the treatment of opioid induced constipation (OIC) in … Continue Reading
Read NowLong Ideas - Amarin Corp. (NASDAQ:AMRN) announced FDA approval of Vascepa last night, a milestone event for the company. Shares are trading lower in the pre-market, however, largely … Continue Reading
Read NowLong Ideas - Speculation on the future of Alzheimer’s treatments has been at the forefront of major pharma and biotech news this month. Pfizer (NYSE:PFE) and Elan’s (NYSE:ELN) … Continue Reading
Read NowLong Ideas - Nuvo Research Inc. announced that the U.S. Patent and Trade Office (PTO) reinstated a patent protecting the company’s Synera Patch through July 2020. Synera is … Continue Reading
Read NowLong Ideas - Novartis AG (NYSE:NVS) announced this morning that its generics division, Sandoz, has completed takeover of private dermatology provider Fougera Pharmaceuticals in a $1.5B deal. Although … Continue Reading
Read NowLong Ideas - Among the next significant events in pharma and biotech is the FDA decision on Kyprolis (carfilzomib), Onyx Pharmaceuticals’ (NASDAQ:ONXX)next-generation treatment for multiple myeloma. On July … Continue Reading
Read NowLong Ideas - Transcept Pharmaceuticals (NASDAQ:TSPT) raised about $38 million on May 1st at $9.00 a share, but given the weak market and the “show me” launch of … Continue Reading
Read Now